Novo Nordisk: How competitive will all degludec-based products be in the US?

NEUTRAL, Fair Value DKK390 (+5%)
News published on September Tuesday 29, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities